Finance

Beta
Lists
FBRX:NASDAQ
Forte Biosciences Inc
$51.12
+7.64%
(+3.63) 1D
Jul 21, 11:05:38 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FBRX...
Open
$49.53
High
$52.67
Low
$49.26
Mkt. cap
1.03B
Avg. vol.
718.22K
Volume
289.39K
52-wk high
$52.67
52-wk low
$9.10
EPS
-$4.58
Beta
2.85
Shares outstanding
20.48M
No. of employees
22
Open
$49.53
High
$52.67
Low
$49.26
Mkt. cap
1.03B
Avg. vol.
718.22K
Volume
289.39K
52-wk high
$52.67
52-wk low
$9.10
EPS
-$4.58
Beta
2.85
Shares outstanding
20.48M
No. of employees
22
News stories
From sources across the web
About Forte Biosciences Inc
CEO-
Employees22
Founded2007
HeadquartersDallas, Texas, United States
SectorBiotechnology
Websitefortebiorx.com
Analyst ratings
Based on 5 analysts giving stock ratings to FBRX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for FBRX in the last 3 months.
Highest
Current $51.12
$75.00 (+46.71%)
Average
$68.75 (+34.49%)
Lowest
$61.00 (+19.33%)
Analyst
Recommendation
Action
Price target
Projected
Date
Etzer Darout
Barclays
Buy
Initiated
$74.00
+44.8%
07/21/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
$75.00
+46.7%
07/09/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
$61.00
+19.3%
05/11/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
05/11/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$65.00
+27.2%
05/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
8.62M
15.20M
21.74M
20.47M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.96M
3.18M
2.84M
1.97M
Operating expense
11.58M
18.38M
24.57M
22.44M
Total operating expenses
11.58M
18.38M
24.57M
22.44M
Operating income
-11.58M
-18.38M
-24.57M
-22.44M
Other non operating income
330.00K
701.00K
-1.65M
676.00K
EBT including unusual items
-11.25M
-17.68M
-23.75M
-21.76M
EBT excluding unusual items
-11.25M
-17.68M
-23.50M
-21.76M
Income tax expense
-
-
1.04M
373.00K
Effective tax rate
-
-
-4.37%
-1.71%
Other operating expenses
-
-
-
-
Net income
-11.25M
-17.68M
-24.79M
-22.14M
Net profit margin
-
-
-
-
Earnings per share
-0.96
-0.99
-1.45
-1.24
Interest and investment income
-
-
2.72M
-
Interest expense
-
-
-
-
Net interest expenses
-
-
2.72M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.56M
-18.37M
-24.55M
-22.42M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer